Multiple Myeloma Research Foundation shared on X:
“The MMRF CoMMpass study is uncovering new biology and vulnerabilities in high-risk MM subtypes. Learn how these findings are driving more effective therapies.”
Read further.
Source: Multiple Myeloma Research Foundation/X